Encumber
发表于 2025-3-25 06:29:50
978-3-540-41718-7Springer-Verlag Berlin Heidelberg 2001
Grating
发表于 2025-3-25 11:16:36
http://reply.papertrans.cn/23/2261/226050/226050_22.png
露天历史剧
发表于 2025-3-25 11:41:54
Deutsche Gesellschaft für Chirurgiehttp://image.papertrans.cn/c/image/226050.jpg
NADIR
发表于 2025-3-25 17:23:05
Chirurgisches Forum 2001 für experimentelle und klinische Forschung978-3-642-56698-1Series ISSN 1432-9336
FLAG
发表于 2025-3-25 23:28:13
http://reply.papertrans.cn/23/2261/226050/226050_25.png
粘土
发表于 2025-3-26 03:08:32
http://reply.papertrans.cn/23/2261/226050/226050_26.png
Leisureliness
发表于 2025-3-26 04:36:41
http://reply.papertrans.cn/23/2261/226050/226050_27.png
Fulsome
发表于 2025-3-26 08:28:29
5-FU-PEG-Liposomen zur intraaortalen Therapie. Ist die Metabolisierung von 5-Fluorouracil (5-FU) in RD concentration was determined here as well. Intra-aortal applications of 5-FU-PEG liposomes increase 5-FU tumor concentrations 40-fold and para-aortal lymph-node concentrations 100-fold compared to i.v. applications. Metabolization of 5-FU to its active metabolite 5-FURD is strongly dependent on the pH value and can be modulated.
Ligneous
发表于 2025-3-26 12:37:50
http://reply.papertrans.cn/23/2261/226050/226050_29.png
树木中
发表于 2025-3-26 17:23:10
Selektive Endothelin-A-Rezeptorblockade reduziert das Wachstum von rezeptorpositiven Pankreaskarzinoprimary tumors, metastasis, and ascites in an orthotopic nude mouse model of ET.A positive MIAPaCa-2 und AsPC-1 tumors, resulting in a tendency towards increased survival. ET-1 seems to modulate the proliferation of pancreatic cancer cells via ET.A. Selective ET.A blockade may provide a novel therapy option for ET.A-positive pancreatic cancers.